MINIMEDTM 780G SYSTEM

 

Life with diabetes 
just got easier for people with type 1 diabetes

Experience the #1 insulin pump in preventing 
highs and lows based on user satisfaction.1*

 

Now available with the 15-day InstinctTM sensor, made by Abbott.

MiniMed 780G system with Instinct sensor, made by Abbott

More time in range2**, day and night.

The MiniMedTM 780G system automatically^ adjusts insulin delivery and corrects glucose levels every 5 minutes 24/7, requiring no finger pricks^,^^

Time in range3

Real world data shows the
Overnight average
Time in Range4,#,∞

MiniMedTM 780G system

Now available for children with diabetes ages 2 years old+ and women during pregnancy.

Considering an automated insulin pump system?

When choosing an insulin pump, make sure it meets your needs and delivers the best results. Key considerations should include:


Time in Range (TIR):
The percentage of time your blood glucose levels are within the target range. Higher TIR reduces complications like eye damage (retinopathy), heart and kidney disease.1


Burden reduction:
Achieve more while doing less.  Your pump should help you to stay in range even when carb counting isn't exact.

Learn more about the MiniMedTM 780G system

Want to learn more about the MiniMedTM 780G system?

Leave your details and we will contact you to answer all your questions.

indicates a required field.

What type of diabetes do you have?

This field is required.

Sorry, Our pump therapy is approved for type 1 diabetes. Please contact your HCP if you have type 2 diabetes.

This field is required.
This field is required.
This field is required.
This field is required.
This field is required.
This field is required.
*
This field is required.
*
This field is required.

Are you currently using a Medtronic diabetes therapy?

This field is required.
This field is required.
This field is required.

For more information on how MiniMed handles your personal (health) data and your rights as a data subject – follow the link to MiniMed’s Privacy Statement. You can withdraw your consent at any time by accessing your profile account on the website and contacting your local MiniMed team.

I understand that the information provided is not intended to be a substitute for professional medical advice, diagnosis or treatment in any manner and that I should also contact my diabetes care team at my hospital or clinic for further advice relating to my individual circumstances.

We have received your submission. Thank you!

One of our Therapy Consultants will reach out to you within the next 48 working hours.

References
  1. Choudhary P, et al. Diabetes Technol Ther 2024; 26 (Suppl. 3): S32-S37.
  2. De Meulemeester J. The association of chronic complications with time in tight range and time in range in people with type 1 diabetes: a retrospective cross-sectional real-world study. Diabetologia. 2024;67(8):1527-1535. doi:10.1007/s00125-024-06171-y
  3. Petrovski G, et al. Diabetes Care 2023;46(3):544–550
  4. Di Molfetta S, Di Gioia L, Caruso I, et al. Efficacy and Safety of Different Hybrid Closed Loop Systems for Automated Insulin Delivery in People With Type 1 Diabetes: A Systematic Review and Network Meta-Analysis. Diabetes Metab Res Rev. 2024;40(6):e3842. doi:10.1002/dmrr.3842
  5. dQ&A Diabetes Technology Report, 2024 (n= 2,721)
  6. Fusselman H, et al. FUSS2015D-P - The Extended Wear Infusion Set - A Design for Plastic Waste Reduction. Virtual Diabetes Technology Meeting. 2020

* Compared to MDI + isCGM
** Refer to System User Guide - SmartGuardTM feature. Some user interaction required
^ A blood glucose (BG) reading is needed when entering SmartGuardTM feature. If glucose alerts and CGM readings do not match your symptoms, use a BG meter to make diabetes treatment decisions. Refer to System User Guide - SmartGuardTM feature. Some user interaction required.
^^ Multiple Daily Injections (3 bolus and 1 basal insulin per day) requires 28 injections per week vs. 1 with MiniMed Extended Infusion Set.
# Arrieta A, et al. Diabetes Obes Metab. 2022;24(7):1370-1379. Mean 80% TIR is reached using the recommended optimal settings of 2 hours active insulin time and 5.5 mmol/L as glucose target for at least 90% of the time.
~ The patients testimonials relates an account of an individual´s response to the treatment. The account is genuine, typical and documented. However, the individual´s response does not provide any indication, guide, warranty or guarantee as to the response other patients may have to the treatment. The response other patients have to the treatment could be different. Responses to the treatment discussed can and do vary and specific to the individual patient.
¥ Refer to Accu-Chek® Guide Link User's Manual

Frequently asked questions

Get in touch